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Objectives. To review the aetiology and method of treatment of all femoral artery false aneurysms from a single centre
during the last 9 years.
Design. Retrospective case-note study.
Methods. All patients with a diagnosis of false aneurysm were identified from the hospital data-base between January 1995
and September 2003. A manual search of the case-notes was performed, and data collected on the location, cause and method
of repair of the false aneurysm. For all patients with a diagnosis of femoral artery false aneurysm, the patients’ medical and
drug history and admission time attributable to the false aneurysm were recorded.
Results. One hundred and seven patients were identified. Seventy-nine had false aneurysms of the femoral artery. The
majority (40.5%) were caused by coronary angiography, the second commonest cause being breakdown of previous graft
anastomosis (29.1%). Over time, the method of treatment became increasingly radiological (most commonly ultrasound-
guided thrombin injection), resulting in a significantly reduced hospital admission time (P ¼ 0.018).
Conclusions. The incidence of femoral artery false aneurysms appears to be increasing. This is largely a result of an increase
in the number of cardiac interventional and diagnostic procedures performed. The introduction of ultrasound-guided
thrombin-injection has reduced the inpatient stay of patients with femoral false aneurysms.
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Introduction
The management of false aneurysms has traditionally
been conducted by vascular surgeons. In recent years,
the introduction of new radiological techniques such
as ultrasound-guided compression (UGC), ultra-
sound-guided thrombin injection (UGTI) and radio-
logical embolisation have, however, led to a change in
practice in the management of patients with false
aneurysm, by an increase in the potential treatment
options. There has also been recent concern that the
number of patients at risk of femoral artery false
aneurysm may be increasing due to an increase in the
number of cardiac and vascular radiological interven-
tional procedures performed each year. In addition to
this, there are an increasing number of patients that
undergo interventional radiological procedures whilst
being treated with anti-platelet agents, and in particu-
lar, new agents such as glycoprotein IIb/IIIa inhibi-
tors, which inhibit platelet aggregation and thrombus
formation. This may put the patient at further risk of
false aneurysm formation due to inhibition of the
coagulation cascade.1
The aim of this paper is, therefore, to assess how the
incidence and treatment of false aneurysms of the
femoral artery has changed over the last 9 years, using
data from a single centre.
Methods
All patients at the University Hospitals of Leicester
NHS Trust with a diagnosis of false aneurysm were
identified using the vascular audit database. Patients
with a diagnosis of false aneurysm of the femoral
artery were then sub-selected. The study period was
from the start of the database (January 1995) up to and
including August 2003. This was supplemented by a
manual search of radiological records for all interven-
tional procedures conducted after January 1995.
The following information was collected from the
patient’s notes and audit data: the patient’s age, sex,
medical history and drug history, the anatomical
location of the false aneurysm, the cause of false
aneurysm, the method of treatment and the length of
hospital stay.
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Data was also obtained from cardiology records
regarding the numbers of coronary angiograms,
angioplasties and stents performed, and also the
number of patients treated with glycoprotein IIb/IIIa
inhibitors.
Results are expressed as mean values (standard
deviation) where the data is normally distributed, and
as median values (interquartile range) where the data
is not normally distributed.
Results
A total of 107 patients were identified as having a false
aneurysm. In 12 of these, either the notes were not
available, or the record of false aneurysm was
incorrect. Therefore, a total of 95 patients were
included, with 79 (83%) of these having a false
aneurysm of the femoral artery. The locations of false
aneurysms at locations other than the femoral artery
are given in Table 1. These are not further discussed.
The mean age of patients with femoral false
aneurysms was 69.6 (S.D. 9.7) years. Sixty-two percent
of patients were male, and 38% female. The common-
est causal factor of femoral false aneurysms was
previous coronary angiography with or without
angioplasty/stenting, which accounted for 40.5% ðn ¼
32Þ of all cases. The remainder resulted from anasto-
motic breakdown of a previous vascular graft (29.1%,
n ¼ 23), peripheral vascular (not cardiac) angiography
(10.1%, n ¼ 8) and miscellaneous causes (7.6%, n ¼ 6).
The precise aetiology was not clearly documented in
12.7% ðn ¼ 10Þ of cases (Fig. 1). The miscellaneous
causes of femoral false aneurysms are described in
Table 2.
The number of femoral false aneurysms recorded
each year increased, with the number of false
aneurysms resulting from cardiac angioplasty also
increasing (Fig. 2). Sixty-seven percent ðn ¼ 53Þ of false
aneurysms arose from the right femoral artery
(common or superficial), and 33% ðn ¼ 26Þ arose
from the left femoral artery (common or superficial).
With regard to method of repair of false aneurysms,
the majority (41.8%, n ¼ 33) were repaired operatively
by either suturing of the defect or with vein patch
repair. The remainder were treated either with graft
revision (27.8%, n ¼ 22), ultrasound-guided thrombin
injection (24.1%, n ¼ 19), ultrasound-guided com-
pression (2.5%, n ¼ 2), radiological embolisation
(1.3%, n ¼ 1) or stenting (1.3%, n ¼ 1). One patient
was treated conservatively, due to pre-existing comor-
bidity. The method of repair of false aneurysms has
changed since 1995. Looking specifically at false
aneurysms arising as a result of causes other than
graft breakdown, an increasing number are being
treated radiologically (Fig. 3). Ultrasound-com-
pression was, however, found to be unsuccessful at
both attempts, with patients undergoing subsequent
open repair. At present, all false aneurysms resulting
from angiography-related complications are con-
sidered for UGTI.
With regard to admission time, patients experi-
enced a median hospital admission time of 5 (2.0–10.0)
days. Looking specifically at patients having either
open repair or ultrasound-guided thrombin injection
of angiography-related false aneurysms, the median
admission time was 5.5 (4.0–9.25) days in the open
group compared with 1 (1.0–2.5) day in the thrombin
group. This difference is statistically significant
(P ¼ 0:001; Mann–Whitney U test). In addition to
this, the median admission time of patients with
angiography-related false aneurysms has significantly
fallen from 6.0 (4.0–6.5) days to 2.0 (1.0–5.5) days after
the introduction of ultrasound-guided thrombin injec-
tion (P ¼ 0:018 Mann–Whitney U test).
Table 1. Location of non-femoral false aneurysms
Location of false aneurysm Number of cases
Aorta 1
Iliac (common or external) 3
Popliteal 1
Dorsalis pedis 1
Subclavian 2
Axillary 1
Radial 4
Ulnar 1
Inferior epigastric 1
Hepatic 1
Fig. 1. The aetiology of femoral artery false aneurysms.
Table 2. The miscellaneous causes of femoral false aneurysms
Miscellaneous causes of false aneurysm ðn ¼ 6Þ Number of cases
Graft embolectomy 1
Endovascular AAA repair 1
Femoral endarterectomy 1
Femoral artery phlebotomy 1
Cardiac balloon pump 2
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During the study period, the number of cardiolo-
gical procedures increased (Fig. 4). Since the introduc-
tion of glycoprotein IIb/IIIa inhibitors, the number of
patients treated with these agents has also greatly
increased, with 1519 cardiac patients treated between
January 1999 and September 2003 (Fig. 4). Of these,
eight (0.5%) have presented with a documented false
aneurysm. Despite the apparent increase in coronary
angiogram/angioplasty-related false aneurysms,
there is no statistical difference in the actual yearly
rate (P ¼ 0:24 Fisher’s Exact test), with an annual
incidence of between 0.11 and 0.24% of all procedures
performed between January 2000 and September 2003.
Prior to January 2000, the number of procedures
performed could not be calculated.
In comparison with cardiac procedures, patients
undergoing peripheral angiograms/angioplasties had
a lower rate of false aneurysm formation (0.08% of all
procedures performed between January 2000 and
September 2003), although this difference was not
significant (P ¼ 0:24 Fisher’s Exact test).
Comparing specifically patients that had or had not
received a glycoprotein IIb/IIIa inhibitor during a
cardiac angiogram/angioplasty between January 2000
and September 2003, the patients that had received
glycoprotein IIb/IIIa inhibitors had a false aneurysm
rate of 0.57% compared to a rate of 0.19% in those who
did not. This difference was statistically significant
(P ¼ 0:01; Fisher’s Exact test).
Discussion
The data from this study provide a number of
important messages in the aetiology and management
of femoral false aneurysms. Firstly, the aetiology is
changing. Most strikingly, the number of false aneur-
ysms resulting from interventional cardiological pro-
cedures appears to be an increasing, whereas the
number of false aneurysms resulting from graft-
breakdown remains at a similar level. This increase
in cardiology-related false aneurysms is, however, a
reflection of the increasing number of interventional
cardiological procedures performed each year rather
than a true increase. Coronary angiography, angio-
plasty and stenting are recognised risk factors for false
aneurysm formation.2 With the increasing number of
these procedures performed each year, adequate
measures must be taken to ensure prevention against
false aneurysm formation. This is especially important
in patients receiving antithrombotic therapies such as
heparin, warfarin or antiplatelet agents; all of which
are additional risk factors for false aneurysm for-
mation.3 Specific concerns have been attributed to the
new receptor inhibitors of platelet glycoprotein IIb/
IIIa.4 In this study, we have demonstrated that patients
treated with glycoprotein IIb/IIIa inhibitors are at
higher risk of false aneurysm formation, and therefore
prevention against this must be ensured by meticulous
and prolonged pressure on the vessel after the
Fig. 2. The aetiology of femoral artery false aneurysms each
year. Miscellaneous and unknown causes are not included.
Fig. 3. Changes in the method of repair over time.
Fig. 4. Graph demonstrating the number of percutaneous
coronary angioplasties (PTCA), coronary artery stents and
diagnostic coronary angiograms. The number of patients
receiving glycoprotein IIb/IIIa inhibitors is also displayed.
The exact figures for PTCA prior to January 1996, for
diagnostic angiograms prior to January 2000 and for stenting
prior to January 1999 could not be obtained. Glycoprotein
IIb/IIIa inhibitors were introduced in January 1999.
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procedure, and/or with the use of additional methods
of puncture site closure such as the commercially
available percutaneous closure devices.5
Other centres have noticed similar trends,6 attribut-
ing this to the more frequent use of continued
coagulation, and the use of larger catheters for
interventional procedures. The increase in false aneur-
ysms in our centre has occurred in conjunction with a
large increase in the number of invasive cardiological
procedures performed.
Despite increasing numbers of false aneurysms, the
number of operative procedures performed for non
graft-related false aneurysms has not mirrored this
increase due to the increase in radiological procedures
to treat false aneurysms. This increase in radiological
therapeutic procedures has had two important con-
sequences. Firstly, it has reduced the burden on
vascular services, and secondly, it has resulted in a
reduced inpatient hospital stay, thereby reducing the
cost to the hospital and increasing bed availability. The
majority of radiologically treated false aneurysms
utilised the technique of ultrasound-guided thrombin
injection. This has been effective in the management of
angiography-related false aneurysms, and has signifi-
cantly reduced admission time. In agreement to the
findings of recent trials, UGTI was found to be more
effective than ultrasound-guided compression
(UGC).7,8
In conclusion, the data from this study demonstrate
that the incidence, aetiology method of treatment of
false aneurysms has changed over the last 9 years in
our centre, allowing more efficient treatment of the
increasing numbers of false aneurysms.
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